The Food and Drug Administration has updated its patient screening guidance for use of the COVID-19 antiviral pill Paxlovid.
FDA restricts use of antibody sotrovimab in 8 states where BA.2 dominates
By
Alicia Lasek
Mar 29, 2022
The monoclonal antibody sotrovimab is no longer authorized for the treatment of COVID-19 in eight states and two territories where the omicron BA.2 sub-variant accounts for at least half of the infections.
Another mAB bites the dust? FDA advises docs not to use sotrovimab in some locales
By
Alicia Lasek
Feb 25, 2022
In a scenario now familiar to long-term care clinicians, the FDA has advised against prescribing the COVID-19 monoclonal antibody drug sotrovimab in locations where certain SARS-CoV-2 variants are now...
FDA expands use of remdesivir to skilled nursing, other non-hospital settings
By
Alicia Lasek
Jan 25, 2022
Remdesivir, the first FDA-approved COVID-19 drug, now can be used in adult and pediatric patients with mild-to moderate COVID-19 illness at high risk of progressing to severe disease, the agency has announced.
FDA limits use of new dementia drug Aduhelm to mild cognitive impairment only
By
Alicia Lasek
Jul 09, 2021
The FDA’s new label restricts Aduhelm’s use to Alzheimer’s patients with mild cognitive impairment or mild dementia, drugmaker Biogen announced Thursday.
‘Already skeptical’ nursing home workers may need persuading after J&J shots resume, industry leaders...
By
Danielle Brown
Apr 26, 2021
Now that vaccinators are encouraged to resume giving Johnson & Johnson’s COVID-19 shot, nursing home stakeholders are questioning what effect the recent pause will have on vaccine uptake in a wary population.
While FDA moves to halt mask reuse, N95 access remains spotty, report finds
By
Alicia Lasek
Apr 15, 2021
A new push to ensure that healthcare facilities stockpile single-use or reusable N95 respirators has arrived while some workers continue to lack access to the equipment and U.S. mask manufacturers can’t...
FDA says it’s time to move away from mask reuse
By
Alicia Lasek
Apr 13, 2021
Healthcare facilities should move away from decontaminating and reusing disposable masks now that U.S. respirator supply has recovered, the agency says.
Feds authorize combo antibody infusion to treat COVID-19 in older adults with chronic disease
By
Alicia Lasek
Feb 11, 2021
The latest Eli Lilly therapy has received emergency approval for treating mild to moderate COVID-19 in patients at high risk for progressing to severe disease and/or hospitalization. This includes adults...
FDA limits N95 respirator reuse to four times with PPE decontamination systems
By
Alicia Lasek
Jan 26, 2021
The agency last week reissued emergency use authorizations to some manufacturers, allowing compatible N95 respirators to be decontaminated a maximum of four times only.